221 related articles for article (PubMed ID: 3552347)
1. Secondary myelodysplastic syndromes and leukaemias.
Levine EG; Bloomfield CD
Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
[TBL] [Abstract][Full Text] [Related]
2. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.
Levine EG; Bloomfield CD
Semin Oncol; 1992 Feb; 19(1):47-84. PubMed ID: 1736370
[TBL] [Abstract][Full Text] [Related]
3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
4. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
6. High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
Corti C; Theodore C; Bayle C; Rougier P; Nasr F; Cosset JM; Girinsky T; Hayat M; Ribrag V
Hematol Oncol; 1996 Dec; 14(4):159-63. PubMed ID: 9267461
[TBL] [Abstract][Full Text] [Related]
7. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
8. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
9. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
Dührsen U
Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
Kantarjian H; Beran M; Cortes J; O'Brien S; Giles F; Pierce S; Shan J; Plunkett W; Keating M; Estey E
Cancer; 2006 Mar; 106(5):1099-109. PubMed ID: 16435387
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
de Graeff A; Vendrik CP; Pinedo HM
Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
[TBL] [Abstract][Full Text] [Related]
13. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
14. Risk of leukemia after chemotherapy and radiation treatment for breast cancer.
Curtis RE; Boice JD; Stovall M; Bernstein L; Greenberg RS; Flannery JT; Schwartz AG; Weyer P; Moloney WC; Hoover RN
N Engl J Med; 1992 Jun; 326(26):1745-51. PubMed ID: 1594016
[TBL] [Abstract][Full Text] [Related]
15. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.
Takeyama K; Seto M; Uike N; Hamajima N; Ino T; Mikuni C; Kobayashi T; Maruta A; Muto Y; Maseki N; Sakamaki H; Saitoh H; Shimoyama M; Ueda R
Int J Hematol; 2000 Feb; 71(2):144-52. PubMed ID: 10745624
[TBL] [Abstract][Full Text] [Related]
17. Cancer and secondary leukemia.
Rosner F
Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease.
McCarthy CJ; Sheldon S; Ross CW; McCune WJ
Arthritis Rheum; 1998 Aug; 41(8):1493-6. PubMed ID: 9704650
[TBL] [Abstract][Full Text] [Related]
20. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
